Results

Total Results: 339 records

Showing results for "symptoms".

41. Chipra-88-Measure-1-Section-6-Attachment-1 (xls file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-6-attachment-1.xlsx
    June 01, 2012 - chart of assessment of impairment in 2 settings (Yes - 1/No - 2) Evidence in the chart of assessment of symptoms

42. Your Guide to Preventing and Treating Blood Clots | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/patients-consumers/prevention/disease/bloodclots.html
    August 01, 2017 - This guide describes ways to prevent and treat blood clots; symptoms; and medication side effects as … Contents Introduction Causes of Blood Clots Symptoms of a Blood Clot Preventing Blood Clots Treatment … Return to Contents Symptoms of a Blood Clot You may have a blood clot if you see or feel: New

43. Overuse of Imaging for the Evaluation of Children with Simple Febrile Seizure: Technical Specifications (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0192-technicalspecs.pdf
    October 16, 2019 - -9-CM code 783.42) within the 365 days before the simple febrile seizure (Table IMG2) o Signs or symptoms … normal physiological development, or delayed milestones o Family history of seizures o Signs or symptoms

44. Depression Screening and Follow-up for Adolescents and Adults (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-246-fullreport.pdf
    December 01, 2019 - • A depression case management encounter that documented assessment for symptoms of depression or … There are misperceptions that depression symptoms are part of normal aging. … Even minor levels of depression symptoms are associated with decreases in work function (Beck, Crain … Measuring and tracking depressive symptoms is important to improve patient outcomes (Knaup, Koesters … Regular tracking and monitoring of symptoms can help clinicians better understand the effectiveness

45. Depression Care for Adolescents and Adults 2014 Testing Report (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/depression/chipra-246-section-6.pdf
    January 01, 2014 - Utilization of the PHQ-9 to Monitor Depression Symptoms for Adolescents and Adults The percentage … of members 12 years and older with a diagnosis of depression whose symptoms were monitored using a … Utilization of the PHQ-9 to Monitor Depression Symptoms Eligible Population Size The tables below show … Performance Rate by Time Period: Utilization of the PHQ-9 to Monitor Depression Symptoms Product … of depressive symptoms Appendix 2: Measure Specifications Tested Depression Screening and

46. Medication Discrepancies and Potential Adverse Drug Events During Transfer of Care from Hospital to Home | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/patient-safety/reports/liability/neumiller.html
    August 01, 2017 - lasting 30 or more days in 1.3 percent of the cases, symptoms lasting less than 30 days in 47.5 percent … Significant potential ADEs were defined as those that could cause or contribute to symptoms, such as … present 30 days or greater, symptoms present less than 30 days, abnormal lab results, or ADE but with … The most common potential health consequence assessed was “symptoms lasting less than 30 days,” which … Lasting <30 Days 105 (18.5) 159 (28.1) 5 (0.9) Symptoms Lasting ≥30 Days 0 (0) 6 (1.1)

47. Chipra-89-Adhd-Behavior-Section-6-Attach-1 (xls file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-6-attach-1.xlsx
    June 01, 2012 - chart of assessment of impairment in 2 settings (Yes - 1/No - 2) Evidence in the chart of assessment of symptoms

48. Depression Care for Adolescents and Adults: 2014 Testing Report (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0244-testing-report.pdf
    January 01, 2014 - Utilization of the PHQ-9 to Monitor Depression Symptoms for Adolescents and Adults The percentage … of members 12 years and older with a diagnosis of depression whose symptoms were monitored using a … Utilization of the PHQ-9 to Monitor Depression Symptoms Eligible Population Size The tables below show … Performance Rate by Time Period: Utilization of the PHQ-9 to Monitor Depression Symptoms Product … of depressive symptoms Appendix 2: Measure Specifications Tested Depression Screening and

49. Depression Care for Adolescents and Adults: 2014 Testing Report (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0245-testing-report.pdf
    January 01, 2014 - Utilization of the PHQ-9 to Monitor Depression Symptoms for Adolescents and Adults The percentage … of members 12 years and older with a diagnosis of depression whose symptoms were monitored using a … Utilization of the PHQ-9 to Monitor Depression Symptoms Eligible Population Size The tables below show … Performance Rate by Time Period: Utilization of the PHQ-9 to Monitor Depression Symptoms 65+ … of depressive symptoms Appendix 2: Measure Specifications Tested Depression Screening and

50. EvidenceNOW: Managing Urinary Incontinence | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/evidencenow/projects/urinary/index.html
    February 01, 2024 - What’s more, fewer than 50% of women seek care for UI symptoms. … Fewer than 30% of women (> age 40) with UI report receiving any care for UI symptoms, despite available

51. ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-5.pdf
    February 02, 2012 - ADHD for any child 4 through 18 years of age who presents with academic or behavioral problems and symptoms … ● The study also found that many chil­ dren (ages 4–5 years) experience improvements in symptoms … Criteria for this level of severity, based on the multisite-study results,57 are (1) symptoms that … Com­ parison of attention-deficit/hyperactivity disorder symptoms subtypes in Ukrai­ nian schoolchildren … Preva­ lence and correlates of ADHD symptoms in the national health interview survey.

52. Chipra-89-Adhd-Behavior-Section-5-Attach-5 (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-5.pdf
    February 02, 2012 - ADHD for any child 4 through 18 years of age who presents with academic or behavioral problems and symptoms … ● The study also found that many chil- dren (ages 4–5 years) experience improvements in symptoms with … Criteria for this level of severity, based on the multisite-study results,57 are (1) symptoms that have … Preva- lence and correlates of ADHD symptoms in the national health interview survey. … Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyper- activity

53. Nursing Home Resources | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/es/nursing-home/resources/search.html?page=3
    January 01, 2022 - Identification & Prevention series This series of three learning modules focuses on identifying the signs and symptoms … of COVID-19, knowing when and how to report signs and symptoms of COVID-19, and remembering to maintain … COVID-19 Impact Long Haulers This podcast describes the chronic symptoms experienced by many COVID-19

54. Federal Interagency Workgroup on Improving Diagnostic Safety: July Meeting Summary (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/topics/dx-safety-workgroup-meeting-notes-jul2023.pdf
    November 03, 2023 - CMS • RFI-0872 [American College of Emergency Physicians] o Patients with symptoms consistent with a … diagnosis (or whether they have an emergency or nonemergent medical condition) based on the patient’s symptoms … Many conditions share very similar symptoms, and a full workup and examination (sometimes with additional

55. Measure 1, Section 14, Attachment 1 (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-14-attachment-1.pdf
    January 01, 2011 - ADHD medications can reduce symptoms, but might be associated with side effects and symptoms effecting … ADHD medications can reduce symptoms, but might be associated with side effects and symptoms effecting … At least 2 of the 3 follow-up visits with assessment of ADHD symptoms (Inattention, Hyperactivity and … evaluate children 4 -18 years of age for ADHD who present with academic or behavioral problems and symptoms … Improvement There is a need for accurate assessment of the effectiveness of treatment in reducing symptoms

56. ADHD Performance Measurement Set (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-14-attach-1.pdf
    January 01, 2011 - ADHD medications can reduce symptoms, but might be associated with side effects and symptoms effecting … ADHD medications can reduce symptoms, but might be associated with side effects and symptoms effecting … At least 2 of the 3 follow-up visits with assessment of ADHD symptoms (Inattention, Hyperactivity and … Measure 1): Both of the following diagnostic criteria:  Assessment for presence or absence of symptoms … evaluate children 4 -18 years of age for ADHD who present with academic or behavioral problems and symptoms

57. PQMP Measures | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/pqmp/measures/index.html?page=3
    March 30, 2024 - Pediatric Measurement Center of Excellence (PMCoE) Adolescents who present to the ED with psychotic symptoms … Children with Complex Needs (COE4CCN) Children/adolescents admitted to the hospital with psychotic symptoms … Children with Complex Needs (COE4CCN) Children/adolescents admitted to the hospital with psychotic symptoms

58. Patient-Centered Care Takes Center Stage in New Report from AHRQ’s Digital Healthcare Research Program | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/news/blog/ahrqviews/patient-centered-care-dhr.html
    September 01, 2022 - that patients screened for depression using a portal they could access at home showed higher rates of symptoms … Encouraging patients to report their symptoms using an easy-to-access portal and an online questionnaire

59. CAHPS Child Hospital Survey Measures | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/cahps/surveys-guidance/hp/about/child-survey-measures.html
    June 01, 2017 - hospital Q41 Provider explained when child can resume regular activities Q42 Provider explained symptoms … or problems to look for after leaving the hospital Q43 Parent received written information about symptoms

60. Attachments 6.1 through 6.9 (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-vi-a.pdf
    March 01, 2011 - At least 2 of the 3 follow-up visits with assessment of ADHD symptoms (Inattention, Hyperactivity and … diagnostic tool or other acceptable assessment including improvement, deterioration, or stability in ADHD symptoms … At least 2 of the 3 follow-up visits with assessment of ADHD symptoms (Inattention, Hyperactivity and … diagnostic tool or other acceptable assessment including improvement, deterioration, or stability in ADHD symptoms